ResearcherShanghai Jiao Tong UniversityNo recent work listed
Xingya Guo
Matched on OpenAlex author ID A5108662185. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 3
- Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer. Co-author DOI 10.1038/s12276-022-00877-y↗
- RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Co-author DOI 10.1186/s12943-020-01158-w↗
- KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma. Co-author DOI 10.4251/wjgo.v11.i8.599↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Weiliang Jiang · 3 shared papers, 2019–2022 · strength 0.34
- Paper Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer. DOI 10.1038/s12276-022-00877-y↗
- Paper RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF… DOI 10.1186/s12943-020-01158-w↗
- Paper KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma. DOI 10.4251/wjgo.v11.i8.599↗
- Rong Wan · 3 shared papers, 2019–2022 · strength 0.34
- Paper Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer. DOI 10.1038/s12276-022-00877-y↗
- Paper RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF… DOI 10.1186/s12943-020-01158-w↗
- Paper KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma. DOI 10.4251/wjgo.v11.i8.599↗
- Qiuyan Zhao · 2 shared papers, 2019–2022 · strength 0.23
- Zhonglin Zhu · 1 shared paper, 2022 · strength 0.14
- Yinshi Huang · 1 shared paper, 2020 · strength 0.11
- Kai Li · 1 shared paper, 2020 · strength 0.11
- Mingjie Jiang · 1 shared paper, 2019 · strength 0.09
- Sisi Li · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.